MY173288A - Boswellia oil, its fractions and compositions for enhancing brain function - Google Patents

Boswellia oil, its fractions and compositions for enhancing brain function

Info

Publication number
MY173288A
MY173288A MYPI2012700603A MYPI2012700603A MY173288A MY 173288 A MY173288 A MY 173288A MY PI2012700603 A MYPI2012700603 A MY PI2012700603A MY PI2012700603 A MYPI2012700603 A MY PI2012700603A MY 173288 A MY173288 A MY 173288A
Authority
MY
Malaysia
Prior art keywords
boswellia
memory
fraction
fractions
compositions
Prior art date
Application number
MYPI2012700603A
Other languages
English (en)
Inventor
Ganga Raju Gokaraju
Rama Raju Gokaraju
Venkata Kanaka Ranga Raju Gokaraju
Trimurtulu Golakoti
Kiran Bhupathiraju
Original Assignee
Laila Nutraceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laila Nutraceuticals filed Critical Laila Nutraceuticals
Publication of MY173288A publication Critical patent/MY173288A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
MYPI2012700603A 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function MY173288A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN687CH2010 IN2010CH00687A (enExample) 2010-03-15 2011-03-14
PCT/IN2011/000170 WO2011114350A2 (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function

Publications (1)

Publication Number Publication Date
MY173288A true MY173288A (en) 2020-01-13

Family

ID=54291846

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012700603A MY173288A (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function

Country Status (8)

Country Link
CN (1) CN102811728A (enExample)
AU (2) AU2011228689A1 (enExample)
BR (1) BR112012022983A2 (enExample)
CA (1) CA2793045A1 (enExample)
IN (1) IN2010CH00687A (enExample)
MY (1) MY173288A (enExample)
SG (1) SG184006A1 (enExample)
WO (1) WO2011114350A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012502294A1 (en) * 2010-05-30 2021-08-09 Laila Nutraceuticals Compositions comprising non-acidic boswellia oil fraction as a bio-enhancer for enhancing the bioavailability of biological agents
GB201111319D0 (en) 2011-07-04 2011-08-17 Univ Leuven Kath Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
US11759492B2 (en) 2014-10-21 2023-09-19 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Extract from a plant of the genus Boswellia and related products and uses
JP6936151B2 (ja) * 2015-04-13 2021-09-15 エトノディーヌ α−シヌクレイノパチーの治療のためのアシュワガンダ抽出物の使用
CN113648292A (zh) * 2017-05-16 2021-11-16 四川省中医药科学院 四氢姜黄素在制备提高记忆力的药物或保健品中的用途
CN107349190B (zh) * 2017-07-19 2021-04-23 广东工业大学 芳姜黄酮的应用
IT201900013707A1 (it) * 2019-08-01 2021-02-01 Cristalfarma S R L Integratore alimentare, per uso come coadiuvante, per la prevenzione della demenza vascolare
WO2021176469A1 (en) * 2020-03-03 2021-09-10 Laila Nutraceuticals Synergistic compositions for improving brain health
WO2021205083A2 (fr) 2020-04-11 2021-10-14 Finindsutria Srl Composition pour la prévention ou le traitement du covid-19
CN116370523B (zh) * 2023-04-04 2024-08-13 昆明理工大学 植物精油在制备抗癫痫药物或健康产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer
US7873730B2 (en) * 2003-11-10 2011-01-18 International Business Machines Corporation Method and system for collaborative computing environment access restriction and orphan data management
CN1583063B (zh) * 2004-06-10 2012-03-28 山东齐都药业有限公司 乳香有效成分提取方法及提取物制剂和用途
WO2008036932A2 (en) * 2006-09-21 2008-03-27 Herbalscience Singapore Pte. Ltd. Compositions and methods comprising boswellia species

Also Published As

Publication number Publication date
AU2011228689A1 (en) 2012-09-27
AU2016201084B2 (en) 2017-10-19
IN2010CH00687A (enExample) 2011-08-31
SG184006A1 (en) 2012-10-30
WO2011114350A3 (en) 2011-11-10
CN102811728A (zh) 2012-12-05
CA2793045A1 (en) 2011-09-22
WO2011114350A2 (en) 2011-09-22
AU2016201084A1 (en) 2016-03-17
BR112012022983A2 (pt) 2015-09-15

Similar Documents

Publication Publication Date Title
MY173288A (en) Boswellia oil, its fractions and compositions for enhancing brain function
PH12012501787A1 (en) Boswellia oil, its fractions and compositions for enhancing brain function
CY1121136T1 (el) Φυτικα εκχυλισματα που περιεχουν κανναβινοειδη ως νευροπροστατευτικους παραγοντες
MY159856A (en) Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
WO2010021693A3 (en) Mif modulators
WO2012020307A3 (en) Therapeutic uses of microvesicles and related micrornas
WO2011140202A3 (en) Mif modulators
WO2011090738A3 (en) Type ii raf kinase inhibitors
HK1223093A1 (zh) 杀真菌组合物
MX369877B (es) Composiciones y metodos.
MX2012004638A (es) Modulacion de degeneracion de axones.
WO2009062102A3 (en) Compositions and methods for treatment of microbial disorders
WO2008052166A3 (en) Systems and methods for altering brain and body functions an treating conditions and diseases
WO2011133875A3 (en) Metalloenzyme inhibitor compounds
PH12015501806A1 (en) Novel benzopyran kinase modulators
WO2014149138A3 (en) Lice control composition and method
WO2011048617A3 (en) Extracts, fractions and compositions comprising acetogenins and their applications
WO2011082245A3 (en) Metalloenzyme inhibitor compounds
WO2012064943A3 (en) Metalloenzyme inhibitor compounds
EP3581177A3 (en) Compositions comprising acidic extracts of mastic gum
AU2018326393A1 (en) Improving the taste of consumables
WO2014126965A3 (en) Compositions and methods for treating pathological calcification and ossification
WO2012058529A3 (en) Metalloenzyme inhibitor compounds
PH12019501006A1 (en) Synergistic dietary supplement compositions for improving brain health
MY169297A (en) Compositions comprising non-acidic boswellia oil fraction as a bio-enhancer for enhancing the bioavailability of biological agents